microdose glp-1 noom Why We Launched GLP-1RX Noom shifts GLP-1 strategy toward

Together, well help you build realistic, sustainable habits that fit your lifenot a restrictive diet that feels impossible to maintain

At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story

This is the longest fasting period most people experience daily, and it creates ideal conditions for sublingual absorption

A gradual increase in effort leads to better performance and fewer setbacks over time